This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2002 Apr 4;346(14):1085-7.

doi: 10.1056/NEJM200204043461412.

Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?

Ian Chau, David Cunningham

PMID: 11932478
DOI: 10.1056/NEJM200204043461412

Editorial

Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?

Ian Chau et al. N Engl J Med. 2002.

. 2002 Apr 4;346(14):1085-7.

doi: 10.1056/NEJM200204043461412.

Authors

Ian Chau, David Cunningham

PMID: 11932478
DOI: 10.1056/NEJM200204043461412

No abstract available

PubMed Disclaimer

Comment on

Primary chemoprevention of familial adenomatous polyposis with sulindac.
Giardiello FM, Yang VW, Hylind LM, Krush AJ, Petersen GM, Trimbath JD, Piantadosi S, Garrett E, Geiman DE, Hubbard W, Offerhaus GJ, Hamilton SR. Giardiello FM, et al. N Engl J Med. 2002 Apr 4;346(14):1054-9. doi: 10.1056/NEJMoa012015. N Engl J Med. 2002. PMID: 11932472 Free PMC article. Clinical Trial.

Similar articles

The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubet RA. Jacoby RF, et al. Cancer Res. 2000 Sep 15;60(18):5040-4. Cancer Res. 2000. PMID: 11016626
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.
Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B, Godio L, Patterson S, Rodriguez-Bigas MA, Jester SL, King KL, Schumacher M, Abbruzzese J, DuBois RN, Hittelman WN, Zimmerman S, Sherman JW, Kelloff G. Steinbach G, et al. N Engl J Med. 2000 Jun 29;342(26):1946-52. doi: 10.1056/NEJM200006293422603. N Engl J Med. 2000. PMID: 10874062 Clinical Trial.
[Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
Florent C, Meary N. Florent C, et al. Bull Cancer. 2004 May;91 Spec No:S85-8. Bull Cancer. 2004. PMID: 15239335 Review. French.
COX-2 inhibitors cut risk of colon polyps.
[No authors listed] [No authors listed] Health News. 2000 Aug;6(8):6. Health News. 2000. PMID: 10948872 No abstract available.
Aspirin use and potential mechanisms for colorectal cancer prevention.
Williams CS, Smalley W, DuBois RN. Williams CS, et al. J Clin Invest. 1997 Sep 15;100(6):1325-9. doi: 10.1172/JCI119651. J Clin Invest. 1997. PMID: 9294096 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

Colorectal cancer in two pre-teenage siblings with familial adenomatous polyposis.
Jerkic S, Rosewich H, Scharf JG, Perske C, Füzesi L, Wilichowski E, Gärtner J. Jerkic S, et al. Eur J Pediatr. 2005 May;164(5):306-10. doi: 10.1007/s00431-004-1602-y. Epub 2005 Feb 22. Eur J Pediatr. 2005. PMID: 15726412
Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus.
Buskens CJ, Sivula A, van Rees BP, Haglund C, Offerhaus GJ, van Lanschot JJ, Ristimäki A. Buskens CJ, et al. Gut. 2003 Dec;52(12):1678-83. doi: 10.1136/gut.52.12.1678. Gut. 2003. PMID: 14633942 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Research Materials
- NCI CPTC Antibody Characterization Program